Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Fentanyl 23Analgesia 22Morphine 19Acupuncture Therapy 18Zoledronic Acid 15Oxycodone 14Acetaminophen 14Ketamine 13Radiotherapy 12Therapeutics 11Methadone 11Lidocaine 11nabiximols 10Ibandronic Acid 10Hydromorphone 10Bupivacaine 10Surveys and Questionnaires 8Ropivacaine 8Psychiatric Rehabilitation 7Early Intervention, Educational 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5Massage 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain × Glutathione × Clear all
NCT02311907 2017-02-23

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
195 enrolled 12 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡